Cite
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
MLA
Vanessa F. Bonazzi, et al. “Pathogenic Germline Variants Are Associated with Poor Survival in Stage III/IV Melanoma Patients.” Scientific Reports, vol. 10, Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95476bc3fa79b822027b0d80d93826da&authtype=sso&custid=ns315887.
APA
Vanessa F. Bonazzi, Sandra Brosda, Katia Nones, John V. Pearson, Scott Wood, Kalpana Patel, Nicola Waddell, Andrew Barbour, Melissa Arneil, James M. Lonie, Victoria Atkinson, B. Mark Smithers, Lauren G. Aoude, Harald Oey, & Lambros T. Koufariotis. (2020). Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients. Scientific Reports, 10.
Chicago
Vanessa F. Bonazzi, Sandra Brosda, Katia Nones, John V. Pearson, Scott Wood, Kalpana Patel, Nicola Waddell, et al. 2020. “Pathogenic Germline Variants Are Associated with Poor Survival in Stage III/IV Melanoma Patients.” Scientific Reports 10 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95476bc3fa79b822027b0d80d93826da&authtype=sso&custid=ns315887.